A new oral pill for weight loss has been approved by the FDA, with several outlets comparing it to existing weight loss medications, including injectable forms. The pill, which is a form of oral semaglutide, is being compared to other GLP-1 medications, including Wegovy and Ozempic. The differences between these medications, including their forms, potential side effects, and how they work, are being explored by various health and pharmaceutical outlets.